Veracyte DX Reports 53% Revenue Growth for Tutivya Tests

Key Facts

1Veracyte DX recorded a 53% increase in revenue from Tutivya tests.

Veracyte DX recorded a 53% increase in revenue from its Tutivya diagnostic tests. Reuters reported that the significant surge was driven by increased adoption or volume of the Tutivya testing suite within the healthcare sector.

The growth in this core product line serves as a strong performance indicator for the diagnostic firm. The revenue figures highlight continued operational expansion.